Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Profiling Lung Cancer Patients Using Electronic Health Records.

Menasalvas Ruiz E, Tuñas JM, Bermejo G, Gonzalo Martín C, Rodríguez-González A, Zanin M, González de Pedro C, Méndez M, Zaretskaia O, Rey J, Parejo C, Cruz Bermudez JL, Provencio M.

J Med Syst. 2018 May 31;42(7):126. doi: 10.1007/s10916-018-0975-9.

PMID:
29855732
2.

An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement.

Maximiano C, López I, Martín C, Zugazabeitia L, Martí-Ciriquián JL, Núñez MA, Contreras J, Herdman M, Traseira S, Provencio M.

PLoS One. 2018 Apr 3;13(4):e0193233. doi: 10.1371/journal.pone.0193233. eCollection 2018.

3.

Description and Survival of Stage I and II Lung Cancer Patients.

Pérez-Martínez O, Vidal-García I, Montero-Martínez C, Provencio M, Ruano-Ravina A.

Arch Bronconeumol. 2018 Mar 16. pii: S0300-2896(18)30061-9. doi: 10.1016/j.arbres.2018.02.007. [Epub ahead of print] English, Spanish.

4.

Long-term follow up of Hodgkin lymphoma.

Perez-Callejo D, Zurutuza L, Royuela A, Torrente M, Núñez B, Calvo V, Méndez M, Franco F, Brenes MA, Sánchez JC, Provencio M.

Oncotarget. 2018 Feb 3;9(14):11638-11645. doi: 10.18632/oncotarget.24392. eCollection 2018 Feb 20.

5.

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Jurczak W, Zinzani PL, Gaidano G, Goy A, Provencio M, Nagy Z, Robak T, Maddocks K, Buske C, Ambarkhane S, Winderlich M, Dirnberger-Hertweck M, Korolkiewicz R, Blum KA.

Ann Oncol. 2018 May 1;29(5):1266-1272. doi: 10.1093/annonc/mdy056.

6.

Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients.

Provencio M, Torrente M, Calvo V, Pérez-Callejo D, Gutiérrez L, Franco F, Pérez-Barrios C, Barquín M, Royuela A, García-García F, Bueno C, Garcia-Grande A, Camps C, Massuti B, Sotomayor E, Romero A.

Oncotarget. 2017 Nov 16;9(1):488-494. doi: 10.18632/oncotarget.22470. eCollection 2018 Jan 2.

7.

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Arriola E, García Gómez R, Diz P, Majem M, Martínez Aguillo M, Valdivia J, Paredes A, Sánchez-Torres JM, Peralta Muñoz S, Barneto I, Gutierrez V, Andrade Santiago JM, Aparisi F, Isla D, Ponce S, Vicente Baz D, Artal A, Amador M, Provencio M.

BMC Cancer. 2018 Jan 30;18(1):106. doi: 10.1186/s12885-018-4004-7.

8.

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.

Mata E, Díaz-López A, Martín-Moreno AM, Sánchez-Beato M, Varela I, Mestre MJ, Santonja C, Burgos F, Menárguez J, Estévez M, Provencio M, Sánchez-Espiridión B, Díaz E, Montalbán C, Piris MA, García JF.

Oncotarget. 2017 Nov 30;8(67):111386-111395. doi: 10.18632/oncotarget.22799. eCollection 2017 Dec 19.

9.

Mutational profile of primary breast diffuse large B-cell lymphoma.

Franco F, González-Rincón J, Lavernia J, García JF, Martín P, Bellas C, Piris MA, Pedrosa L, Miramón J, Gómez-Codina J, Rodríguez-Abreu D, Machado I, Illueca C, Alfaro J, Provencio M, Sánchez-Beato M.

Oncotarget. 2017 Oct 24;8(61):102888-102897. doi: 10.18632/oncotarget.21986. eCollection 2017 Nov 28.

10.

Twice-daily chemoradiotherapy must still be the choice for patients with limited-stage small-cell lung cancer.

Franco F, Pérez-Callejo D, Provencio M.

J Thorac Dis. 2017 Sep;9(9):2843-2846. doi: 10.21037/jtd.2017.08.113. No abstract available.

11.

PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.

Cruz-Bermúdez A, Vicente-Blanco RJ, Laza-Briviesca R, García-Grande A, Laine-Menéndez S, Gutiérrez L, Calvo V, Romero A, Martín-Acosta P, García JM, Provencio M.

Sci Rep. 2017 Nov 30;7(1):16661. doi: 10.1038/s41598-017-17009-6.

12.

Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.

Abad A, Martínez-Balibrea E, Viéitez JM, Alonso-Orduña V, García Alfonso P, Manzano JL, Massutí B, Benavides M, Carrato A, Zanui M, Gallego J, Grávalos C, Conde V, Provencio M, Valladares-Ayerbes M, Salazar R, Sastre J, Montagut C, Rivera F, Aranda E.

Ann Oncol. 2018 Feb 1;29(2):439-444. doi: 10.1093/annonc/mdx737.

PMID:
29145602
13.

Alcohol consumption and lung cancer risk in never smokers: a pooled analysis of case-control studies.

García Lavandeira JA, Ruano-Ravina A, Kelsey KT, Torres-Durán M, Parente-Lamelas I, Leiro-Fernández V, Zapata M, Abal-Arca J, Vidal-García I, Montero-Martínez C, Amenedo M, Castro-Añón O, Golpe-Gómez A, Guzmán-Taveras R, Martínez C, Provencio M, Mejuto-Martí MJ, García-García S, Fernández-Villar A, Piñeiro M, Barros-Dios JM.

Eur J Public Health. 2018 Jun 1;28(3):521-527. doi: 10.1093/eurpub/ckx196.

PMID:
29140412
14.

Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.

Torres-Durán M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, Leiro-Fernández V, Abdulkader I, Provencio M, Abal-Arca J, Castro-Añón O, Montero-Martínez C, Vidal-García I, Amenedo M, Golpe-Gómez A, Martínez C, Guzmán-Taveras R, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Cancer Lett. 2017 Dec 28;411:130-135. doi: 10.1016/j.canlet.2017.09.042. Epub 2017 Oct 5.

PMID:
28987389
15.

Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment.

Provencio M, Torrente M, Calvo V, Gutiérrez L, Pérez-Callejo D, Pérez-Barrios C, Barquín M, Royuela A, Rodriguez-Alfonso B, Sotelo M, Cruz-Bermúdez JL, Mendez M, Cruz-Bermúdez A, Romero A.

Oncotarget. 2017 Aug 7;8(36):60291-60298. doi: 10.18632/oncotarget.20016. eCollection 2017 Sep 1.

16.

Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients.

Provencio M, Pérez-Callejo D, Torrente M, Martin P, Calvo V, Gutiérrez L, Franco F, Coronado MJ, Cruz-Bermúdez JL, Ruiz-Valdepeñas AM, Cruz-Bermúdez A, Sánchez-Beato M, Romero A, García-Grande A.

Oncotarget. 2017 Jul 31;8(35):59408-59416. doi: 10.18632/oncotarget.19722. eCollection 2017 Aug 29.

17.

mRNA in exosomas as a liquid biopsy in non-Hodgkin Lymphoma: a multicentric study by the Spanish Lymphoma Oncology Group.

Provencio M, Rodríguez M, Cantos B, Sabín P, Quero C, García-Arroyo FR, Rueda A, Maximiano C, Rodríguez-Abreu D, Sánchez A, Silva J, García V.

Oncotarget. 2017 Mar 22;8(31):50949-50957. doi: 10.18632/oncotarget.16435. eCollection 2017 Aug 1.

18.

Lung cancer as a cardiotoxic state: a review.

Pérez-Callejo D, Torrente M, Brenes MA, Núñez B, Provencio M.

Med Oncol. 2017 Aug 9;34(9):159. doi: 10.1007/s12032-017-1012-4. Review.

PMID:
28795306
19.

Lung cancer in lung transplantation: incidence and outcome.

Pérez-Callejo D, Torrente M, Parejo C, Laporta R, Ussetti P, Provencio M.

Postgrad Med J. 2018 Jan;94(1107):15-19. doi: 10.1136/postgradmedj-2017-134868. Epub 2017 Aug 4.

PMID:
28778949
20.

Exercise and the Hallmarks of Cancer.

Ruiz-Casado A, Martín-Ruiz A, Pérez LM, Provencio M, Fiuza-Luces C, Lucia A.

Trends Cancer. 2017 Jun;3(6):423-441. doi: 10.1016/j.trecan.2017.04.007. Epub 2017 Jun 3. Review.

PMID:
28718417
21.

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

Remon J, Isla D, Garrido P, de Castro J, Majem M, Viñolas N, Artal A, Carcereny E, García-Campelo MR, Lianes P, Provencio M, Juan O, Diz P, Blanco R, Lopez-Castro R, Maestu I, Vadell C, Felip E.

Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.

PMID:
28660482
22.

A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib.

Moran T, Palmero R, Provencio M, Insa A, Majem M, Reguart N, Bosch-Barrera J, Isla D, Costa EC, Lee C, Puig M, Kraemer S, Schnell D, Rosell R.

Lung Cancer. 2017 Jun;108:154-160. doi: 10.1016/j.lungcan.2017.03.009. Epub 2017 Mar 22.

PMID:
28625629
23.

Small Cell Lung Cancer. Methodology and Preliminary Results of the SMALL CELL Study.

Rodríguez-Martínez Á, Ruano-Ravina A, Torres-Durán M, Vidal-García I, Leiro-Fernández V, Hernández-Hernández J, García-García S, Provencio M, Castro-Añón O, Parente-Lamelas I, Abdulkader I, Abal-Arca J, Montero-Martínez C, Amenedo M, Guzmán-Taveras R, Fernández-Villar A, Barros-Dios JM.

Arch Bronconeumol. 2017 Dec;53(12):675-681. doi: 10.1016/j.arbres.2017.04.016. Epub 2017 Jun 15. English, Spanish.

24.

Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.

Provencio M, Royuela A, Torrente M, Pollán M, Gómez-Codina J, Sabín P, Llanos M, Gumá J, Quero C, Blasco A, Aguiar D, García-Arroyo FR, Lavernia J, Martínez N, Morales M, Saenz-Cusi Á, Rodríguez D, Calvo V, de la Cruz-Merino L, de la Cruz MÁ, Rueda A; Spanish Lymphoma Oncology Group.

Cancer. 2017 Oct 1;123(19):3709-3716. doi: 10.1002/cncr.30795. Epub 2017 Jun 13.

PMID:
28608996
25.

Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.

Provencio M, Sabín P, Gomez-Codina J, Torrente M, Calvo V, Llanos M, Gumá J, Quero C, Blasco A, Cruz MA, Aguiar D, García-Arroyo F, Lavernia J, Martinez N, Morales M, Saez-Cusi A, Rodriguez D, de la Cruz L, Sanchez JJ, Rueda A; GOTEL (Spanish Lymphoma Oncology Group).

PLoS One. 2017 May 11;12(5):e0177204. doi: 10.1371/journal.pone.0177204. eCollection 2017.

26.

Follicular lymphomas and their transformation: Past and current research.

Mendez M, Torrente M, Provencio M.

Expert Rev Hematol. 2017 Jun;10(6):515-524. doi: 10.1080/17474086.2017.1326812. Epub 2017 May 16. Review.

PMID:
28480766
27.

Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer.

Palka M, Sanchez A, Córdoba M, Nuevo GD, De Ugarte AV, Cantos B, Méndez M, Calvo V, Maximiano C, Provencio M.

Oncol Lett. 2017 Mar;13(3):1647-1654. doi: 10.3892/ol.2017.5620. Epub 2017 Jan 18.

28.

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC.

Chaib I, Karachaliou N, Pilotto S, Codony Servat J, Cai X, Li X, Drozdowskyj A, Servat CC, Yang J, Hu C, Cardona AF, Vivanco GL, Vergnenegre A, Sanchez JM, Provencio M, de Marinis F, Passaro A, Carcereny E, Reguart N, Campelo CG, Teixido C, Sperduti I, Rodriguez S, Lazzari C, Verlicchi A, de Aguirre I, Queralt C, Wei J, Estrada R, Puig de la Bellacasa R, Ramirez JL, Jacobson K, Ditzel HJ, Santarpia M, Viteri S, Molina MA, Zhou C, Cao P, Ma PC, Bivona TG, Rosell R.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx014.

29.

Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

Viñolas N, Garrido P, Isla D, Provencio M, Majem M, Artal A, Carcereny E, Garcia Campelo R, Lianes P, De La Peñas R, Felip E.

Cancer Invest. 2017 May 28;35(5):358-365. doi: 10.1080/07357907.2017.1295461. Epub 2017 Mar 28.

PMID:
28350480
30.

Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.

Pérez-Barrios C, Nieto-Alcolado I, Torrente M, Jiménez-Sánchez C, Calvo V, Gutierrez-Sanz L, Palka M, Donoso-Navarro E, Provencio M, Romero A.

Transl Lung Cancer Res. 2016 Dec;5(6):665-672. doi: 10.21037/tlcr.2016.12.03.

31.

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.

Isla D, Felip E, Viñolas N, Provencio M, Majem M, Artal A, Bover I, Lianes P, DE Las Peñas R, Catot S, DE Castro J, Blasco A, Terrasa J, Gonzalez-Larriba JL, Juan O, Dómine M, Bernabe R, Garrido P.

Anticancer Res. 2016 Dec;36(12):6647-6653.

PMID:
27919997
32.

Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.

Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R; Spanish Lung Cancer Group.

Clin Lung Cancer. 2017 Mar;18(2):178-188.e4. doi: 10.1016/j.cllc.2016.08.007. Epub 2016 Nov 9.

PMID:
27908619
33.

Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group.

Franco Pérez F, Lavernia J, Aguiar-Bujanda D, Miramón J, Gumá J, Álvarez R, Gómez-Codina J, Arroyo FG, Llanos M, Marin M, Alfaro J, Quero C, Delgado M, Nogales E, Menarguez F, Martinez N, Torrente M, Royuela A, Abreu D, Provencio M.

Clin Lymphoma Myeloma Leuk. 2017 Mar;17(3):186-191. doi: 10.1016/j.clml.2016.09.004. Epub 2016 Sep 17.

34.

Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.

Pérez-Callejo D, Romero A, Provencio M, Torrente M.

Transl Lung Cancer Res. 2016 Oct;5(5):455-465. Review.

35.

Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.

Ruano-Ravina A, Torres-Durán M, Kelsey KT, Parente-Lamelas I, Leiro-Fernández V, Abdulkader I, Abal-Arca J, Montero-Martínez C, Vidal-García I, Amenedo M, Castro-Añón O, Golpe-Gómez A, González-Barcala J, Martínez C, Guzmán-Taveras R, Provencio M, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Eur Respir J. 2016 Nov;48(5):1462-1470. doi: 10.1183/13993003.00407-2016. Epub 2016 Oct 6.

36.

Spotlight on the relevance of mtDNA in cancer.

Cruz-Bermúdez A, Vicente-Blanco RJ, Gonzalez-Vioque E, Provencio M, Fernández-Moreno MÁ, Garesse R.

Clin Transl Oncol. 2017 Apr;19(4):409-418. doi: 10.1007/s12094-016-1561-6. Epub 2016 Oct 24. Review.

PMID:
27778302
37.

CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway.

Martínez-Martínez E, Martín-Ruiz A, Martín P, Calvo V, Provencio M, García JM.

Oncotarget. 2016 Oct 18;7(42):68781-68791. doi: 10.18632/oncotarget.11968.

38.

Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.

Martin P, Martínez-Velasquez J, Coronado MJ, Krsnik I, Provencio M, Navarro B, Moraru M, Bellas C, Vilches C, Gomez-Lozano N.

Leuk Lymphoma. 2017 Feb;58(2):438-444. Epub 2016 Jun 7.

PMID:
27267403
39.

Survival in young adults diagnosed with follicular lymphoma.

Calvo V, Provencio M, Gómez Codina J, Rodríguez Abreu D, Rueda A.

Ann Oncol. 2016 Apr;27(4):751. doi: 10.1093/annonc/mdv627. Epub 2015 Dec 28. No abstract available.

PMID:
26715622
40.

Small cell lung cancer in never-smokers.

Torres-Durán M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, Provencio M, Leiro-Fernández V, Abal-Arca J, Montero-Martínez C, Vidal-Garcia I, Pena C, Castro-Añón O, Golpe-Gómez A, Martínez C, Guzmán-Taveras R, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

Eur Respir J. 2016 Mar;47(3):947-53. doi: 10.1183/13993003.01524-2015. Epub 2015 Dec 23.

41.

Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.

Almagro-Casado E, Sánchez A, Cantos B, Salas C, Pérez-Callejo D, Provencio M.

Clin Transl Oncol. 2016 Jan;18(1):99-106. doi: 10.1007/s12094-015-1342-7. Epub 2015 Nov 3.

PMID:
26530956
42.

Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.

Rodríguez M, Silva J, Herrera A, Herrera M, Peña C, Martín P, Gil-Calderón B, Larriba MJ, Coronado MJ, Soldevilla B, Turrión VS, Provencio M, Sánchez A, Bonilla F, García-Barberán V.

Oncotarget. 2015 Dec 1;6(38):40575-87. doi: 10.18632/oncotarget.5818.

43.

Alpha-1 Antitrypsin Deficiency and Lung Cancer Risk: A Case-Control Study in Never-Smokers.

Torres-Durán M, Ruano-Ravina A, Parente-Lamelas I, Abal-Arca J, Leiro-Fernández V, Montero-Martínez C, Pena C, Castro-Añón O, Golpe-Gómez A, González-Barcala FJ, Martínez C, Guzmán-Taveras R, Provencio M, Mejuto-Martí MJ, Fernández-Villar A, Barros-Dios JM.

J Thorac Oncol. 2015 Sep;10(9):1279-1284. doi: 10.1097/JTO.0000000000000609.

44.

HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.

Martín P, Krsnik I, Navarro B, Provencio M, García JF, Bellas C, Vilches C, Gomez-Lozano N.

PLoS One. 2015 Aug 11;10(8):e0135512. doi: 10.1371/journal.pone.0135512. eCollection 2015.

45.

Action and resistance of monoclonal CD20 antibodies therapy in B-cell Non-Hodgkin Lymphomas.

Pérez-Callejo D, González-Rincón J, Sánchez A, Provencio M, Sánchez-Beato M.

Cancer Treat Rev. 2015 Sep;41(8):680-9. doi: 10.1016/j.ctrv.2015.05.007. Epub 2015 May 19. Review.

PMID:
26045227
46.

Residential radon and lung cancer characteristics in never smokers.

Torres-Durán M, Ruano-Ravina A, Parente-Lamelas I, Leiro-Fernández V, Abal-Arca J, Montero-Martínez C, Pena-Álvarez C, Castro-Añón O, Golpe-Gómez A, Martínez C, Guzmán-Taveras R, Mejuto-Martí MJ, Provencio M, Fernández-Villar A, Barros-Dios JM.

Int J Radiat Biol. 2015 Aug;91(8):605-10. doi: 10.3109/09553002.2015.1047985. Epub 2015 Jun 17.

PMID:
25968558
47.

Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival.

Martínez-Martínez E, Gómez I, Martín P, Sánchez A, Román L, Tejerina E, Bonilla F, Merino AG, de Herreros AG, Provencio M, García JM.

Oncoscience. 2015 Feb 9;2(2):131-41. eCollection 2015.

48.

Insight in paranoia: The role of experiential avoidance and internalized stigma.

Valiente C, Provencio M, Espinosa R, Duque A, Everts F.

Schizophr Res. 2015 May;164(1-3):214-20. doi: 10.1016/j.schres.2015.03.010. Epub 2015 Mar 29.

PMID:
25823400
49.

Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer.

Provencio M, Sánchez A.

Transl Lung Cancer Res. 2014 Apr;3(2):89-94. doi: 10.3978/j.issn.2218-6751.2014.03.06. Review.

50.

Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.

Esteban E, Majem M, Martinez Aguillo M, Martinez Banaclocha N, Dómine M, Gómez Aldaravi L, Juan O, Cajal R, Gonzalez Arenas MC, Provencio M.

Cancer Epidemiol. 2015 Jun;39(3):291-7. doi: 10.1016/j.canep.2015.02.003. Epub 2015 Mar 9.

PMID:
25766256

Supplemental Content

Loading ...
Support Center